Asked by: Wendy Chamberlain (Liberal Democrat - North East Fife)
Question to the Department for International Trade:
To ask the Secretary of State for International Trade, whether the Government supports the World Trade Organisation proposed waiver for covid-19 intellectual property.
Answered by Greg Hands
The Government has long-supported affordable and equitable access to medicines, including in developing countries. A robust and fair intellectual property system is essential to drive innovation, allow economic growth and enable society to benefit from knowledge sharing. There are flexibilities within the Agreement for the Trade-Related Aspects of Intellectual Property Rights and World Trade Organisation (WTO) Members can use these to ensure access to medicines. The Department for International Trade welcomes initiatives such as Diatropix launched this week in Dakar – where British and Senegalese partners will share technology to produce COVID-19 antibody tests, making 10 million available across west Africa by the end of March 2021. This initiative, supported by development funding from the UK and elsewhere, will make a practical difference in the fight against COVID-19.
Asked by: Wendy Chamberlain (Liberal Democrat - North East Fife)
Question to the Department for International Trade:
To ask the Secretary of State for International Trade, whether she has discussed the role of the proposed Office for the Internal Market with her foreign counterparts as part of trade talks.
Answered by Ranil Jayawardena
There have been no discussions with foreign counterparts about the Office for the Internal Market (OIM) as set out in the United Kingdom Internal Market Bill. HM Government has been clear that the purpose of the OIM is to support the effective operation of the United Kingdom internal market by providing non-binding advice and reporting.